Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Shire LLC
Current Parent Company: Takeda Pharmaceutical
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $1,850,000
Year: 2022
Date: January 26, 2022
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Shire agreed to pay more than $1.8 million to indirect purchasers to settle litigation alleging that it and Actavis conspired to delay the introduction of a generic version of the attention deficit disorder drug Intuniv.
Level of Government: federal
Action Type: private litigation
Court: District of Massachusetts
Civil or Criminal Case: civil
Case ID: 1:16cv12396
Case Name: Picone V. Shire U.S. Inc. et al (Indirect Purchaser Antitrust Class Action)
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.